GLG1

GLG1 (identified independently as MG-160, ESL-1, and CFR-1) is a type I transmembrane cysteine-rich sialoglycoprotein that resides predominantly in the medial cisternae of the Golgi apparatus but also traffics to the cell surface, where roughly 80% of surface labeling concentrates on microvilli that initiate leukocyte–endothelial contacts (PMID:2909545, PMID:9099943). Its subcellular partitioning is encoded by distinct protein regions: the C-terminal cytoplasmic tail confers Golgi retention while an alternatively spliced tail or the cysteine-rich juxtamembrane repeat region directs/destabilizes surface display (PMID:15797922, PMID:21777203). At the cell surface, fucosylated GLG1 acts as a high-affinity E-selectin ligand on myeloid cells, converting initial E-selectin tethers into steady slow rolling — a role distinct from PSGL-1 and CD44 — and is required for hematopoietic progenitor migration into bone marrow (PMID:7531823, PMID:17442598, PMID:24106206). Through its cysteine-rich repeats GLG1 also binds basic FGF and modulates FGF18/FGFR3c signaling, behaving as an FGF-binding/decoy receptor whose activity depends on surface localization (PMID:7768993, PMID:21777203). Independently of E-selectin, GLG1 forms a complex with the latency-associated peptide of TGF-β1 and limits TGF-β availability in the bone marrow niche, restraining excess TGF-β that otherwise drives aberrant HSPC quiescence and niche expansion (PMID:9182700, PMID:26742601). GLG1 additionally binds adiponectin via N-terminal extracellular residues, contributing to suppression of monocyte adhesion (PMID:26792720). GLG1 function is shaped by its glycosylation: FUT3-mediated Lewis-a glycosylation at defined N-glycosites governs its intracellular vesicle distribution and supports gastric cancer cell migration and invasion (PMID:39477144).

1. 1989 High

   Established GLG1's baseline identity and residence — defining it as a Golgi-resident sialoglycoprotein before any functional role was known.

   Evidence Immunoelectron microscopy and biochemical characterization of MG-160 in neurons, glia, and PC12 cells

   PMID:2909545

   Open questions at the time

   • No molecular function assigned at this stage
   • Sequence/domain architecture not yet resolved
2. 1995 High

   Defined GLG1's first molecular activity by showing the affinity-purified protein is the major E-selectin ligand on myeloid cells and requires fucosylation for binding.

   Evidence Affinity isolation with E-selectin-IgG, cell adhesion assays, antibody blocking, and cDNA cloning

   PMID:7531823

   Open questions at the time

   • In vivo contribution to leukocyte rolling not yet tested
   • Specific fucosylated glycan structures not mapped
3. 1995 High

   Linked GLG1 structure to growth-factor biology by demonstrating direct bFGF binding and a 16-cysteine-rich-repeat architecture homologous to chicken CFR.

   Evidence cDNA sequencing, domain analysis, and direct bFGF binding assay with rat brain protein

   PMID:7768993

   Open questions at the time

   • Downstream signaling consequence of FGF binding not established here
   • Whether binding occurs in Golgi or at surface unresolved
4. 1997 High

   Reconciled the Golgi-resident and ligand identities by showing GLG1 also localizes to cell-surface microvilli, positioning it for leukocyte–endothelial contact.

   Evidence Immunofluorescence, surface biotinylation, surface immunoprecipitation, and immunogold SEM in 32Dc13 cells and neutrophils

   PMID:9099943

   Open questions at the time

   • Mechanism partitioning Golgi vs surface pools not yet defined
   • Functional necessity of microvillar localization untested
5. 1997 High

   Revealed a third activity — complex formation with TGF-β1 latency-associated peptide — establishing GLG1 as a component of secreted latent TGF-β complexes.

   Evidence Biochemical purification, amino acid sequencing, and immunoprecipitation of LTCP-1/TGF-β1 in CHO cells

   PMID:9182700

   Open questions at the time

   • Physiological consequence for TGF-β signaling not addressed
   • Binding interface on GLG1 not mapped
6. 2005 Medium

   Identified the cytoplasmic tail as the localization determinant by showing an alternatively spliced isoform (GLG2) with a divergent tail retains the protein in the Golgi, whereas the GLG1 tail targets the surface.

   Evidence cDNA cloning, chimeric cytoplasmic-domain transfection in HEK293, and Northern blot

   PMID:15797922

   Open questions at the time

   • Trafficking machinery recognizing each tail unknown
   • Relative abundance of isoforms in vivo not quantified
7. 2007 High

   Assigned GLG1 a non-redundant step in leukocyte adhesion — converting E-selectin tethers to slow rolling — distinct from PSGL-1 and CD44.

   Evidence Knockout and siRNA loss-of-function with intravital microscopy and combined-knockout epistasis

   PMID:17442598

   Open questions at the time

   • Molecular signaling triggered by GLG1–E-selectin engagement not defined
8. 2009 Low

   Extended E-selectin ligand function to hepatic stellate cells and raised shedding as a possible regulatory mechanism.

   Evidence Flow cytometry, CFR cDNA transfection, secreted binding-activity assay, and qRT-PCR under hypoxia

   PMID:19148508

   Open questions at the time

   • Shedding inferred from supernatant activity, not directly demonstrated
   • Single lab, expression-focused
   • Hypoxic regulation mechanism unclear
9. 2011 Medium

   Mapped two opposing localization signals and connected surface display to function by showing a GPI-anchored surface form modulates FGF18/FGFR3c signaling.

   Evidence Mutagenesis, chimeric GPI-anchored constructs, fractionation, and FGF18 signaling assays in Ba/F3 cells

   PMID:21777203

   Open questions at the time

   • Endogenous balance of the two signals not quantified
   • Direct effect on FGFR3c phosphorylation not detailed
10. 2013 High

    Established the in vivo division of labor between GLG1 and PSGL-1 — GLG1 dominant for progenitor homing, PSGL-1 for mature neutrophils.

    Evidence Single and double knockout mice, flow cytometry, intravital microscopy, bone marrow transplantation

    PMID:24106206

    Open questions at the time

    • Cell-type basis of the dominance switch not mechanistically explained
11. 2016 High

    Demonstrated a cell-intrinsic, E-selectin-independent role for GLG1 in limiting TGF-β in the HSPC niche, with TGF-β blockade rescuing the phenotype.

    Evidence Knockout mice, transplantation, TGF-β cytokine measurement, and in vivo/in vitro TGF-β blockade

    PMID:26742601

    Open questions at the time

    • Molecular step by which GLG1 restrains TGF-β production not defined
    • Relation to the LAP complex from 1997 not directly tested
12. 2016 Medium

    Identified adiponectin as a new GLG1 binding partner and mapped the interaction to five N-terminal extracellular residues, linking GLG1 to anti-adhesive signaling.

    Evidence Anti-adiponectin IP/mass spectrometry, serial mutagenesis, shRNA knockdown, and monocyte–endothelial adhesion assays

    PMID:26792720

    Open questions at the time

    • Knockdown only partially abrogated the effect
    • Downstream signaling pathway unresolved
13. 2024 Medium

    Showed that FUT3-mediated Lewis-a glycosylation at defined N-glycosites controls GLG1 vesicle distribution and supports gastric cancer cell migration and invasion.

    Evidence Lea-antibody capture mass spectrometry, immunofluorescence, siRNA of GLG1 and FUT3, migration/invasion assays

    PMID:39477144

    Open questions at the time

    • Causal link between glycosylation, localization, and invasion not fully separated
    • Single cancer model
14. 2025 Low

    Identified an upstream post-transcriptional control point, with FTO-mediated m6A demethylation stabilizing GLG1 mRNA and promoting gastric cancer aggressiveness.

    Evidence FTO and GLG1 knockdown in vitro and in xenografts, western blot, qRT-PCR, m6A analysis

    PMID:41287415

    Open questions at the time

    • m6A sites on GLG1 mRNA not mapped
    • Knockdown-based, single lab
    • Mechanism of stability change unspecified

• How GLG1 mechanistically restrains TGF-β production in the niche, and whether its Golgi FGF-binding and surface E-selectin/adiponectin roles are coordinately regulated by a single trafficking switch, remain unresolved.
• No structural model of GLG1 with any ligand
• Integration of multiple ligand activities into one regulatory logic unestablished